Anuh Pharma Limited (ANUHPHR.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹79.16 (+2.41%) as of
Key statistics
- Market cap
- 7.93B
- P/E (TTM)
- 17.95
- Forward P/E
- 6.47
- EPS (TTM)
- 4.41
- Dividend yield
- 1.94%
- 52-week range
- 66.72 – 99.50
- Beta
- 0.48
- Revenue (TTM)
- 7.79B
- Profit margin
- 5.67%
- Volume
- 4.99k
About Anuh Pharma Limited
Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-hypertension, expectorant, anti-diabetics, anti-bacterial, anti-gout, anti asthmatics, quinolones, anti biotic, anti platelet, anti-histamines, and intermediates; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, and anti-mitotic. The company also develops products, such as anticoagulant, antagonist, anti convulsants, anty-ulcerative, anty-ulcerative, anticholinergics, anti-anemic, antidepressant, and mucolytic agents. It also exports its products. Anuh Pharma Limited was incorporated in 1960 and is headquartered in Mumbai, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Mumbai, India
- Employees
- 323
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.